Table 2.
Descriptive statistics of quality of life by EORTC QLQ-C30 and self-efficacy by GSE at all three measurement time points T0, T1, and T2 (upper part), and regression model with age and self-efficacy predicting QoL (lower part)
| Outcome | N | M | SD (SE) | S (SE) | K (SE) |
|---|---|---|---|---|---|
| EORTC T0 | 20 | 60.00 | 22.330 (4.993) | − 0.847 (0.512) | − 0.657 (0.992) |
| EORTC T1 | 20 | 57.90 | 23.633 (5.284) | − 0.522 (0.512) | − 0.520 (0.992) |
| EORTC T2 | 20 | 63.35 | 22.843 (5.108) | − 0.167 (0.512) | − 1.070 (0.992) |
| GSE T0 | 18 | 28.28 | 3.997 (0.942) | − 0.752 (0.536) | 1.831 (1.038) |
| GSE T1 | 16 | 29.44 | 2.502 (0.626) | 0.021 (0.564) | 1.312 (1.091) |
| GSE T2 | 17 | 29.65 | 2.548 (0.618) | − 0.708 (0.550) | 1.836 (1.063) |
| Predictor | β | βse | t | p |
|---|---|---|---|---|
| Intercept | − 26.104 | 19.530 | − 1.337 | 0.203 |
| GSEintervention | 3.951 | 1.545 | 2.558 | ≤ 0.05 |
| Age | 0.650 | 0.351 | 1.850 | 0.086 |
Total R2 = 0.319 (F(2) = 3.278; p = 0.068; N = 16). All analyses were conducted outlier-corrected
EORTC European Organization for Research and Treatment of Cancer-Related Quality of Life (EORTC QLQ-C30), GSE General Self-Efficacy Scale